Explained risk from apoB-containing lipoproteins to MI
Should there be more attention for VLDL-cholesterol with regard to MI risk in patients with high CV risk?
This video was recorded in response to a recent publication in J Am Coll Cardiol. by prof. Børge Nordestgaard and colleagues.
Prof. Børge Nordestgaard, MD - Professor, University of Copenhagen, Denmark/ Chief Physician, Dept. Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital Denmark.
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.